Initiatiefnota van de leden Ploumen, Van Gerven en Ellemeet: “Big Farma: niet gezond!”

This motion, introduced by members Ploumen, Van Gerven, and Ellemeet, addresses concerns regarding the influence and business practices of large pharmaceutical companies. It aims to evaluate how the industry impacts public health and the affordability of medicine. The procedure focuses on the pharmaceutical sector and may affect how the Dutch government regulates drug pricing and interacts with global health corporations.